Main Article Content
containing 50% w/w PEG 600 as plasticizer, to choose the most appropriate enhancer and its optimum concentration to be used to achieve the maximum release and permeation of the drug. The addition of various enhancers, as isopropylmyristate (IPM; 0.2_5% w/w), oleic acid (OA; 0.2_5% w/w) and linoleic acid (LOA; 0.2_5% w/w), Tween 80 (T80;1_10% w/w) and transcutol, (TC; 1_10% w/w) enhanced the DFS release from the polymeric films. The enhancement ratio of the penetration enhancers used in the formulation of DFS were found to increase in the order of IPM>LOA>OA>T80>TC.
(56.2, 54.1, 50, 48.7 and 48%, respectively). In vitro permeation studies were performed using rabbit abdominal skin as the permeating membrane. The results indicated that maximum permeation was obtained at 24hrs (0.5% IPM, 0.2% LOA, 1% OA, 0.5% T80 and 10% TC, increased skin permeation of DFS by 4.46, 4.06, 3.37, 1.65 and 1.49 time, respectively). IPM was found to be the most efficient enhancer. The results obtained from ANOVA test indicate that the difference in drug permeation rates is highly significant compared to the control formulation (P<0.05). The mechanism of drug release from
the polymeric films obey Higuchiâ€™s model.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Benson HA. Transdermal drug delivery: Penetration enhancement
techniques. Curr Drug Deliv 2005;2:23-33.
Kumar R, Philip A. Modified transdermal technologies: Breaking the
barriers of drug permeation via the skin. Trop J Pharma Res 2007;6:633-44.
Denyer SP, Guy RH, Hadgraft J, Hugo WB. The microbial degradation
of topically applied drugs. Int J Pharm 1985;26:89-97.
Pannatier A, Jenner P, Testa B, Etter JC. The skin as a drug metabolizing
organ. Drug Metab Rev 1978;8:319-43.
Choi HG, Rhee JD, Yu BK, Yong CS. The Effect of Enhancers on the
Penetration of Clenbuterol through Hairless Mouse Skin. J Korean
Pharm Sci 2003;33:29-36.
Mukherjee B, Mahapatra SK, Das S, Patra B. Sorbitan Monolaurate 20
as a Potential Skin Permeation. J Appl Res 2005;1:96-108.
Xiangqun Xu, Qiuhong Zhu. Evaluation of skin optical clearing
enhancement with Azone as a penetration enhancer. Opt Commun
Panigrahi L, Pattnaik, S, Ghosal SK. The effect of pH and organic ester
penetration enhancers on skin permeation kinetics of terbutaline
sulfate from pseudolatex-type transdermal delivery systems through
mouse and human cadaver skins. AAPS Pharm Sci Tech 2005;6:167-73.
Shaila L, Pandey S, Udupa N. Design and evaluation of matrix type and
membrane controlled transdermal delivery systems of nicotine suitable
for use in smoking cessation. Indian J Pharm Sci 2006: 68: 179-84
Bijaya G, Harivardhan RL, Raghvendra VK, Jasmina K. Comparison of
skin permeability of drugs in mice and human cadaver skin. Indian J
Exp Biol 2000;l38:42-5.
Hanan MM. PhD. Thesis, Faculty of Pharmacy. Egypt: Zagazig University; 2001.
Wade Hull MS. Heat-enhanced transdermal drug delivery: A survey
paper. J Appl Res 2002;2:1-9.
Krishnaiah YS, Chandrasekhar DV, Rama B, Jayaram B, Satyanarayana
V, Al-Saidan SM. In vitro evaluation of limonene-based transdermal
therapeutic system of nicorandil in healthy human volunteers. Skin
Pharmacol Physiol 2004;18:263-72.
Dhanikula AB, Panchagnula R. Development and characterization of
biodegradable chitosan films for local delivery of Paclitaxel. AAPS J
Heng PW, Chan LW, Ong KT. Influence of storage conditions and type
of plasticizers on ethylcellulose and acrylate films formed from aqueous
dispersions. J Pharm Sci 2003;6:334-44.
Venkateshwari Y, Jayachandra RB, Sampath Kumar D, Mittal N, Pandit
JK. Development of low coast tetracycline strip for long term treatment
of periodontal disease. Indian Drugs 1995;32:205-9
Mohamed A, Yasmin S, Asgar A. Matrix type transdermal drug delivery
systems of metoprolol tartrate: In vitro characterization. Acta Pharm
Shah HS, Tojo K, Chien YW. T0 ransdermal controlled delivery of
verapamil: Characterization of in vitro skin permeation. Int J Pharm
Squillante E, Needham T, Zia H. Solubility and in vitro transdermal
permeation of nifedipine. Int J Pharm 1997;159:171-80.
Ghosh TK, Adir J, Xiang S, Onyilofur S. Transdermal delivery of
Metoprolol II: In vitro skin permeation and bioavailability in hairless
rats. J Pharm Sci 1995;84:158-60
Libermann, Lachman. Pharmaceutical dosage forms. 2 nd ed.
Philadelphia, PA: Lea and Febiger; 1990. p. 265.
Winter GA, Risley EA, Nuss GW. Carrageenin-induced edema in hind
paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol
Sang CC, Wonjun H. Anti-inflammatory activity of ketoprofen gel on
carrageenan-induced paw edema in rats. J Pharm Sci 1990;79:974-7.
Wu T, Pan W, Chen J, Zhang R. Studies of the drug permeability and
mechanical properties of free films prepared by cellulose acetate
pseudolatex coating system. Drug Dev Ind Pharm 2001;26:95-102.
Heng PW, Chan LW, Ong KT. Influence of storage conditions and type of
plasticizers on ethylcellulose and acrylate films formed from aqueous
dispersions. J Pharm Pharm Sci 2003;6:334-44.
Verma PR, Murthy TE. Transdermal flurbiprofen delivery using HPMC
matrices: Design, in vitro and in vitro evaluation. Drug Dev Ind Pharm
Leichtnam ML, Rolland H, WÃ¼thrich P, Guy RH. Identification of
penetration enhancers for testosterone transdermal delivery from
spray formulations. J Control Release 2006;113:57-62.
Saunders J, Davis H, Coetzee L, Botha S, Kruger A, Grobler A. A novel
skin penetration enhancer: Evaluation by membrane diffusion and
confocal microscopy. J Pharm Pharmaceut Sci 1999;2:99-107.
Sarisuta N, Saowakontha R, Ruangsuksriwong, C. Effects of surfactant
on release characteristics of clonidine hydrochloride from ethylcellulose
film. Drug Dev Ind Pharm 1999;25:373-7.
Mortazavi SA, Aboofazeli R. Investigation into the effect of various
penetration enhancers on percutaneous absorption of piroxicam.
Iranian J Pharma Res 2003;2:135-40.
Mura P, Faucci MT, Bramanti G, Corti P. Evaluation transcutol as
a clonazepam Transdermal permeation enhancer hydrophilic gel
formulations. Eur J Pharm Sci 2000;9:365-72.
Karandea P, Mitragotrib S. Enhancement of transdermal drug
delivery via synergistic action of chemicals. Biochim Biophys Acta